300016 北陆药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.9714.7240.823-4.1880.621
总资产报酬率 ROA (%)1.3252.9320.471-2.5450.394
投入资产回报率 ROIC (%)1.4943.3130.529-2.8260.443

边际利润分析
销售毛利率 (%)46.51945.80747.67447.00855.390
营业利润率 (%)17.1379.150-0.061-11.276-1.734
息税前利润/营业总收入 (%)18.75112.2305.198-6.3883.554
净利润/营业总收入 (%)14.4077.3550.027-9.341-0.594

收益指标分析
经营活动净收益/利润总额(%)73.82546.271-332.39156.298165.688
价值变动净收益/利润总额(%)15.25256.679585.4507.873-139.154
营业外收支净额/利润总额(%)-0.375-1.62623.9900.70810.020

偿债能力分析
流动比率 (X)2.3922.3972.5733.3323.892
速动比率 (X)1.8041.7291.7772.6502.979
资产负债率 (%)28.34827.79338.55736.64331.766
带息债务/全部投入资本 (%)20.96220.41332.97231.74827.091
股东权益/带息债务 (%)360.749372.224192.592204.874258.021
股东权益/负债合计 (%)236.351242.778145.255159.771198.395
利息保障倍数 (X)11.1773.7900.985-1.2850.648

营运能力分析
应收账款周转天数 (天)68.04463.39365.02758.85656.390
存货周转天数 (天)194.268205.536212.280198.714277.242